HbA1c and the Risk of Lower Limb Ulcers Among Diabetic Patients: An Observational and Genetics Study

Guojun Guo1, Yunlong Guan2, Yuhuan Chen2

  • 1Department of Hand Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

PubMed

Insights

High blood sugar, measured by glycated hemoglobin (HbA1c), significantly increases the risk of developing lower limb ulcers in diabetic patients. Maintaining HbA1c below 53 mmol/mol is recommended to reduce ulcer incidence.

Area of Science:

  • Endocrinology
  • Diabetology
  • Vascular Medicine

Background:

  • Lower limb ulcers are a severe complication of diabetes mellitus.
  • The precise relationship between glycated hemoglobin (HbA1c) and lower limb ulceration requires further investigation.

Purpose of the Study:

  • To comprehensively assess the association between HbA1c levels and the risk of lower limb ulcers in diabetic individuals.
  • To explore potential causal links using observational and Mendelian randomization (MR) methods.

Main Methods:

  • A prospective cohort study involving 23,434 diabetic patients from the UK Biobank.
  • Utilized Cox proportional hazard models and one-sample Mendelian randomization analyses to evaluate HbA1c-ulcer risk association.

Main Results:

  • Over 290,677 person-years, 1101 lower limb ulcer cases were recorded.
  • Higher HbA1c levels demonstrated a dose-dependent increase in lower limb ulcer risk, particularly above 53 mmol/mol.
  • Mendelian randomization analyses indicated a positive, though not statistically significant, association.

Conclusions:

  • Elevated HbA1c levels are a significant risk factor for lower limb ulcers in the diabetic population.
  • An HbA1c target below 53 mmol/mol is suggested to mitigate the incidence of diabetic foot ulcers.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetic Foot Ulcer01:31

Diabetic Foot Ulcer

Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...